Suppr超能文献

关于德尔托啡肽在血浆和脑匀浆中的降解情况。

On the degradation of the deltorphin peptides by plasma and brain homogenate.

作者信息

Marastoni M, Tomatis R, Balboni G, Salvadori S, Lazarus L H

机构信息

Department of Pharmaceutical Sciences, University of Ferrara, Italy.

出版信息

Farmaco. 1991 Nov;46(11):1273-9.

PMID:1667359
Abstract

The peptidase-resistance of deltorphins (DEL-A, H-Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2) and (DEL-C, H-Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2), highly selective and potent agonists of the delta opioid receptor, were investigated in vitro. DEL-C was fully resistant to degradation by rat plasma and strongly resistant to degradation by rat brain homogenates. DEL-A was cleaved with a half-life of 131.6 min upon incubation with plasma, and 57.4 min with rat brain homogenates. N-terminal truncated sequences of DEL-A and -C with free carboxyl groups, were also analyzed for receptor binding activity using [3H] DADLE for delta sites and [3H] DAGO for mu sites. The high enzymatic stability associated with deltorphins and their degradation products may make them prime candidates to characterize the role of delta-receptors in vivo.

摘要

在体外研究了强啡肽(DEL-A,H-Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2)和(DEL-C,H-Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2)的肽酶抗性,它们是δ阿片受体的高选择性和强效激动剂。DEL-C对大鼠血浆降解完全抗性,对大鼠脑匀浆降解具有强抗性。DEL-A与血浆孵育时的半衰期为131.6分钟,与大鼠脑匀浆孵育时为57.4分钟。还使用用于δ位点的[3H] DADLE和用于μ位点的[3H] DAGO分析了具有游离羧基的DEL-A和-C的N端截短序列的受体结合活性。强啡肽及其降解产物相关的高酶稳定性可能使它们成为表征δ受体在体内作用的主要候选物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验